Slow Capital Inc. raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 11.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,004 shares of the semiconductor company’s stock after buying an additional 1,782 shares during the quarter. Synopsys comprises 1.0% of Slow Capital Inc.’s portfolio, making the stock its 25th biggest position. Slow Capital Inc.’s holdings in Synopsys were worth $8,883,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of SNPS. Vanguard Group Inc. grew its holdings in Synopsys by 1.6% during the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after purchasing an additional 231,014 shares during the period. State Street Corp boosted its position in shares of Synopsys by 1.2% during the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after purchasing an additional 85,662 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Synopsys by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after buying an additional 51,043 shares during the period. Ameriprise Financial Inc. increased its position in shares of Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after buying an additional 585,494 shares in the last quarter. Finally, Alliancebernstein L.P. raised its stake in Synopsys by 10.9% during the 2nd quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after buying an additional 187,790 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Price Performance
NASDAQ SNPS opened at $516.31 on Tuesday. The firm’s 50 day moving average is $457.66 and its 200-day moving average is $504.61. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $98.78 billion, a PE ratio of 64.62, a price-to-earnings-growth ratio of 4.30 and a beta of 1.12. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the company. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and cut their price objective for the company from $525.00 to $500.00 in a report on Monday, December 8th. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. KeyCorp upped their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Finally, Morgan Stanley increased their price objective on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $553.57.
Read Our Latest Research Report on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Wall Street Alert: Buy AES
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
- A U.S. “birthright” claim worth trillions – activated quietly
- Trump Did WHAT??
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
